Top 20 Biopharma Acquisitions of 2018 Based on the Total Deal Value
Biopharma acquisition activity in 2018 shows a significant increase over the previous year. Takeda proved to be on top with the acquisition of
[Read More...]
Endocyte
Novartis to Acquire Endocyte for Expansion of its Investigational Radioligand Therapy (RLT) Platform
Shots: Endocyte to receive $24M/share in cash with total deal value of $2.1B. Novartis to get hold of all stocks with its RLT
[Read More...]